A. Lin

Lung Cancer Management Clinical and research priorities for combined modality therapy in stage III NSCLC

A. Bezjak, A. Lin, 2016 .

Lung cancer eight years after radioactive seed migration

A. Bezjak, A. Sun, S. Keshavjee, 2016 .

The benefit of deep inspiration breath hold: evaluating cardiac radiation exposure in patients after mastectomy and after breast-conserving surgery

Do-Hoon Kim, T. Whelan, W. Sharieff, 2016, Breast Cancer.

Clinical outcomes of pancoast tumors treated with trimodality therapy

M. Humer, J. Siever, A. Lin, 2020, Journal of thoracic disease.

Treatment With Stereotactic Ablative Radiotherapy for Up to 5 Oligometastases in Patients With Cancer: Primary Toxic Effect Results of the Nonrandomized Phase 2 SABR-5 Clinical Trial.

A. Mestrovic, N. Chng, S. Tyldesley, 2022, JAMA oncology.

Clinical and research priorities for combined modality therapy in stage III NSCLC.

A. Bezjak, A. Lin, 2016, Lung cancer management.

Phase II Randomized Trial Comparing Proton Craniospinal Irradiation with Photon Involved-Field Radiotherapy for Patients with Solid Tumor Leptomeningeal Metastasis

L. Deangelis, N. Lee, R. Young, 2022, International Journal of Radiation Oncology*Biology*Physics.

Should organs at risk (OARs) be prioritized over target volume coverage in stereotactic ablative radiotherapy (SABR) for oligometastases? A secondary analysis of the population-based phase II SABR-5 trial.

A. Mestrovic, N. Chng, S. Tyldesley, 2023, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.